" class="no-js "lang="en-US"> Matt Hancock Archives - Medtech Alert
Thursday, March 30, 2023

Sort by:


Top Post

NHS Slashes Longest Elective and Cancer Patient Waiting Lists

The number of people waiting over 18 months for NHS care has fallen again despite […]

ReStart and Better Announce a Partnership to Improve Data Interoperability Within the NHS

ReStart and Better have signed a partnership agreement to improve interoperability between NHS organisations, regardless of […]

£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery

Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]

Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive

Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]

More than 30 Million People Vaccinated with Second Dose

More than 30 million people in the UK have been vaccinated with a second dose […]

£36 Million Boost for AI Technologies to Revolutionise NHS Care

New technology will help detect cancers and provide mental health support Projects are part of […]

Sir Richard Sykes Appointed Chair of Vaccine Taskforce

Sir Richard will use his extensive experience in biotechnology and pharmaceuticals to lead the significant […]

Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics

Life science industry leaders are joining forces with governments to step up collective efforts to […]

New UK Strategy Sets out Ambition to Be World Leaders in Organ Donation and Transplantation

Increasing consent rates for organ donation and making the most of donated organs for transplant […]

Eddie Gray Appointed Chair of Antivirals Taskforce

The UK government has appointed Eddie Gray as the new chair of the Antivirals Taskforce. […]

NHS Treats First Patient with the ‘World’s Most Expensive Drug’

A five-month old baby has become the first patient to receive a potentially life-saving drug […]

  1. Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Read more
  2. Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Read more
  3. Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Read more
  4. Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
  5. Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more